DePuy Synthes (Imaging & Robotics)
Johnson & Johnson MedTech's orthopedic and neurosurgical operating company — major global orthopedic-implant maker alongside Stryker, Zimmer Biomet, and Smith & Nephew. Imaging / robotics footprint is the VELYS Robotic-Assisted Solution for orthopedic surgery and the MONARCH Platform for bronchoscopy. Direct competitor to Stryker Mako, Zimmer Biomet ROSA, and Smith & Nephew CORI in the orthopedic-robotics category.
Company history
- 1895 — DePuy founded in Warsaw, Indiana (first U.S. orthopedic company).
- 1958 — Synthes founded (Switzerland).
- 1998 — Johnson & Johnson acquires DePuy.
- 2012 — Johnson & Johnson acquires Synthes; DePuy + Synthes merged into DePuy Synthes.
- 2018 — acquires Auris Health (Monarch bronchoscopy robotics).
- 2020s — VELYS robotic-arthroplasty launches; Monarch installed base in bronchoscopy / lung-biopsy programs.
Product line (imaging / robotics)
Orthopedic robotics
- VELYS Robotic-Assisted Solution — robotic-arm-assisted total knee arthroplasty.
Bronchoscopy robotics
- MONARCH Platform — robotic bronchoscopy + biopsy for peripheral pulmonary lesions; competitor to Intuitive Ion.
Implants + instruments
- Outside scope of the imaging vault.
Distinctive technology
- VELYS Robotic-Assisted Solution — robotic TKA paired with Attune knee implant family; imageless workflow with intra-operative registration.
- MONARCH — robotic bronchoscopy navigates peripheral airways for biopsy of suspicious lung nodules; CBCT integration in modern workflow.
- VELYS Insights — surgical-data analytics platform.
Market position
Top-four orthopedic-robotics vendor alongside Stryker Mako (dominant), Zimmer Biomet ROSA, and Smith & Nephew CORI. VELYS is newer than Mako / ROSA; growing installed base. MONARCH is one of two major robotic-bronchoscopy platforms (Intuitive Ion is the other).
Refurb posture
- Vendor-led service contracts dominate; secondary-market activity limited.
- Implant-tied workflow — VELYS TKA installs typically pair with Attune implant adoption.